Literature DB >> 21756955

HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder.

Pichili Vijaya Bhaskar Reddy1, Nimisha Gandhi, Thangavel Samikkannu, Zainulabedin Saiyed, Marisela Agudelo, Adriana Yndart, Pradnya Khatavkar, Madhavan P N Nair.   

Abstract

HIV infection affects the central nervous system resulting in HIV associated neurocognitive disorder (HAND), which is characterized by depression, behavioral and motor dysfunctions. The HIV-1 viral envelope protein gp120 is known to induce the release of neurotoxic factors which lead to apoptotic cell death. Although the exact mechanisms involved in HIV-1 gp120-induced neurotoxicity are not completely understood, oxidative stress is suggested to play a vital role in the neuropathogenesis of HAND. Astrocytes represent major population of the non-neuronal cell type in the brain and play a critical role in the neuropathogenesis of HAND. Increased oxidative stress is known to induce nuclear factor erythroid derived 2-related factor 2 (Nrf2), a basic leucine zipper transcription factor which is known to regulate the antioxidant defensive mechanism. However, the role of Nrf2 in HAND has not been elucidated. We report that gp120 significantly upregulates Nrf2 in human astrocytes and is associated with stimulation of key antioxidant defensive enzymes Hemoxygenase (HO-1) and NAD(P)H dehydrogenase quinone1 (Nqo1). Pretreatment of the astrocytes with antioxidants or a specific calcium chelator BAPTA-AM, significantly blocked the upregulation of Nrf2, HO-1 and Nqo1. These results suggest a possible role of the intracellular calcium and oxidative stress in Nrf2 mediated antioxidant defense mechanism, which may have protective role in promoting cell survival.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756955      PMCID: PMC3222741          DOI: 10.1016/j.neuint.2011.06.011

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  59 in total

Review 1.  Free radicals and antioxidants in normal physiological functions and human disease.

Authors:  Marian Valko; Dieter Leibfritz; Jan Moncol; Mark T D Cronin; Milan Mazur; Joshua Telser
Journal:  Int J Biochem Cell Biol       Date:  2006-08-04       Impact factor: 5.085

2.  Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1.

Authors:  Truyen Nguyen; Philip J Sherratt; Paul Nioi; Chung S Yang; Cecil B Pickett
Journal:  J Biol Chem       Date:  2005-07-06       Impact factor: 5.157

3.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

4.  Platelet-derived growth factor protects neurons against gp120-mediated toxicity.

Authors:  Fuwang Peng; Navneet Dhillon; Shannon Callen; Honghong Yao; Sirosh Bokhari; Xuhui Zhu; Hicham H Baydoun; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

5.  Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

Authors:  Lucette A Cysique; Paul Maruff; Bruce J Brew
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 6.  HIV and antiretroviral therapy in the brain: neuronal injury and repair.

Authors:  Ronald Ellis; Dianne Langford; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

7.  Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276.

Authors:  Mark P Seldon; Gabriela Silva; Nadja Pejanovic; Rasmus Larsen; Isabel Pombo Gregoire; Josina Filipe; Josef Anrather; Miguel P Soares
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

8.  Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress.

Authors:  Hong Zhu; Zhenquan Jia; Li Zhang; Masayuki Yamamoto; Hara P Misra; Michael A Trush; Yunbo Li
Journal:  Exp Biol Med (Maywood)       Date:  2008-04

9.  N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction.

Authors:  Valeria Visalli; Carolina Muscoli; Iolanda Sacco; Francesca Sculco; Ernesto Palma; Nicola Costa; Carmela Colica; Domenicantonio Rotiroti; Vincenzo Mollace
Journal:  BMC Neurosci       Date:  2007-12-06       Impact factor: 3.288

10.  Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; R Lee Mosley; David J Volsky; Pawel Ciborowski; Howard E Gendelman
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more
  30 in total

Review 1.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 3.  Glutamate metabolism and HIV-associated neurocognitive disorders.

Authors:  Fabián J Vázquez-Santiago; Richard J Noel; James T Porter; Vanessa Rivera-Amill
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

Review 4.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

5.  Inhibition of nuclear factor erythroid 2-related factor 2 exacerbates HIV-1 gp120-induced oxidative and inflammatory response: role in HIV associated neurocognitive disorder.

Authors:  Pichili Vijaya Bhaskar Reddy; Marisela Agudelo; Venkata S R Atluri; Madhavan P Nair
Journal:  Neurochem Res       Date:  2012-04-25       Impact factor: 3.996

6.  An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes.

Authors:  Anusha Ande; Ravinder Earla; Mengyao Jin; Peter S Silverstein; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  Drug Alcohol Depend       Date:  2012-04-11       Impact factor: 4.492

Review 7.  Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

Authors:  Neha Vartak-Sharma; Shruthi Nooka; Anuja Ghorpade
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

Review 8.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

9.  Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment.

Authors:  Scott J Schachtele; Shuxian Hu; James R Lokensgard
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes.

Authors:  Ankit Shah; Peter S Silverstein; Santosh Kumar; Dhirendra P Singh; Anil Kumar
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.